Optimal Sequencing of Pembrolizumab (MK-3475) and Standard Platinum-based Chemotherapy in First-Line NSCLC
Non-Small Cell Lung Cancer Lung Neoplasms Carcinoma, Non-Small-Cell Lung Paclitaxel Pembrolizumab Albumin-Bound Paclitaxel Carboplatin Pemetrexed MK-3475
Lead Scientist at UC Health
- Lyudmila Bazhenova (ucsd)
Dr. Bazhenova’s clinical practice and research concentrate on lung cancer, particularly as this relates to females and non-smokers. She actively participates in cooperative group trials, and takes an active role in designing and implementing clinical investigations, including phase II studies and correlative science projects with several UCSD investigators.
- accepting new patients
- Start Date
- Completion Date
- Alliance Foundation Trials, LLC.
- Phase 2
- Study Type
- Last Updated